MoneyWorks4Me

Alivus Life Sciences - Quaterly Results

31 Jul 2026 Evaluate
The Revenue for the quarter ended  June 2026 of Rs. 6404.14 millions grew by 6.41 % from Rs. 6018.46 millions.A good growth in profit of 31.71% reported to Rs. 1600.76  millions over Rs. 1215.35 millions of corresponding previous quarter.Operating Profit saw a handsome growth to 2341.15 millions from 1812.96 millions in the quarter ended June 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 6404.14 6018.46 6.41 6404.14 6018.46 6.41 25518.32 23868.84 6.91
Other Income 224.01 89.85 149.32 224.01 89.85 149.32 604.11 345.70 74.75
PBIDT 2341.15 1812.96 29.13 2341.15 1812.96 29.13 8576.95 7171.54 19.60
Interest 13.07 12.51 4.48 13.07 12.51 4.48 53.72 24.14 122.54
PBDT 2328.08 1800.45 29.31 2328.08 1800.45 29.31 8266.66 7147.40 15.66
Depreciation 205.85 170.64 20.63 205.85 170.64 20.63 753.57 606.09 24.33
PBT 2122.23 1629.81 30.21 2122.23 1629.81 30.21 7513.09 6541.31 14.86
TAX 521.47 414.46 25.82 521.47 414.46 25.82 1868.26 1685.04 10.87
Deferred Tax 18.73 25.10 -25.38 18.73 25.10 -25.38 29.34 60.64 -51.62
PAT 1600.76 1215.35 31.71 1600.76 1215.35 31.71 5644.83 4856.27 16.24
Equity 245.48 245.26 0.09 245.48 245.26 0.09 245.47 245.07 0.16
PBIDTM(%) 36.56 30.12 21.36 36.56 30.12 21.36 33.61 30.05 11.87

Alivus Life Sciences Share Price

1384.30 10.75 (0.78%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: